Effects of 3-year denosumab treatment on hip structure in Japanese postmenopausal women and men with osteoporosis

Denosumab, a human monoclonal antibody against RANK ligand, is shown to have strong anti-fracture effects in Japanese osteoporosis patients. However, there have been no data showing actions on Japanese bone architecture. Here we show that denosumab continuously improves several geometrical parameter...

Descripción completa

Detalles Bibliográficos
Autores principales: Sone, Teruki, Kon, Naohiro, Gaither, Kenneth W., Okubo, Naoki, Osakabe, Taisuke, Nakayama, Yutaka, Fukunaga, Masao, Ito, Masako, Nakamura, Toshitaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5701790/
https://www.ncbi.nlm.nih.gov/pubmed/29188222
http://dx.doi.org/10.1016/j.bonr.2017.11.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5701790/
https://www.ncbi.nlm.nih.gov/pubmed/29188222
http://dx.doi.org/10.1016/j.bonr.2017.11.002

Ejemplares similares